290 related articles for article (PubMed ID: 7641210)
1. Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 proto-oncogene expression in human breast cancer cells.
Teixeira C; Reed JC; Pratt MA
Cancer Res; 1995 Sep; 55(17):3902-7. PubMed ID: 7641210
[TBL] [Abstract][Full Text] [Related]
2. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
Lykkesfeldt AE; Madsen MW; Briand P
Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
[TBL] [Abstract][Full Text] [Related]
3. Antiestrogens are pro-apoptotic in normal human breast epithelial cells.
Somaï S; Chaouat M; Jacob D; Perrot JY; Rostène W; Forgez P; Gompel A
Int J Cancer; 2003 Jul; 105(5):607-12. PubMed ID: 12740907
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of apoptosis-related bcl-2 but not bcl-xL or bax proteins in multidrug-resistant MCF-7/Adr human breast cancer cells.
Ogretmen B; Safa AR
Int J Cancer; 1996 Sep; 67(5):608-14. PubMed ID: 8782646
[TBL] [Abstract][Full Text] [Related]
5. Differential sensitivity of MCF-7 and LCC2 cells, to multiple growth inhibitory agents: possible relation to high bcl-2/bax ratio?
Lilling G; Hacohen H; Nordenberg J; Livnat T; Rotter V; Sidi Y
Cancer Lett; 2000 Dec; 161(1):27-34. PubMed ID: 11078910
[TBL] [Abstract][Full Text] [Related]
6. Different expression patterns of Bcl-2 family genes in breast cancer by estrogen receptor status with special reference to pro-apoptotic Bak gene.
Eguchi H; Suga K; Saji H; Toi M; Nakachi K; Hayashi SI
Cell Death Differ; 2000 May; 7(5):439-46. PubMed ID: 10800077
[TBL] [Abstract][Full Text] [Related]
7. Oestrogen-mediated suppression of tumour necrosis factor alpha-induced apoptosis in MCF-7 cells: subversion of Bcl-2 by anti-oestrogens.
Burow ME; Weldon CB; Tang Y; McLachlan JA; Beckman BS
J Steroid Biochem Mol Biol; 2001 Nov; 78(5):409-18. PubMed ID: 11738551
[TBL] [Abstract][Full Text] [Related]
8. Regulation of BAX and BCL-2 expression in breast cancer cells by chemotherapy.
Gibson LF; Fortney J; Magro G; Ericson SG; Lynch JP; Landreth KS
Breast Cancer Res Treat; 1999 May; 55(2):107-17. PubMed ID: 10481938
[TBL] [Abstract][Full Text] [Related]
9. Estrogen increases intracellular p26Bcl-2 to p21Bax ratios and inhibits taxol-induced apoptosis of human breast cancer MCF-7 cells.
Huang Y; Ray S; Reed JC; Ibrado AM; Tang C; Nawabi A; Bhalla K
Breast Cancer Res Treat; 1997 Jan; 42(1):73-81. PubMed ID: 9116321
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of chemotherapeutic agents on the Bcl-2/Bax apoptosis pathway in human breast cancer cell line MCF-7.
Leung LK; Wang TT
Breast Cancer Res Treat; 1999 May; 55(1):73-83. PubMed ID: 10472781
[TBL] [Abstract][Full Text] [Related]
11. Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis.
Lewis-Wambi JS; Kim HR; Wambi C; Patel R; Pyle JR; Klein-Szanto AJ; Jordan VC
Breast Cancer Res; 2008; 10(6):R104. PubMed ID: 19061505
[TBL] [Abstract][Full Text] [Related]
12. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.
Pink JJ; Jordan VC
Cancer Res; 1996 May; 56(10):2321-30. PubMed ID: 8625307
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of miR-195 increases the sensitivity of breast cancer cells to Adriamycin treatment through inhibition of Raf-1.
Yang G; Wu D; Zhu J; Jiang O; Shi Q; Tian J; Weng Y
Oncol Rep; 2013 Aug; 30(2):877-89. PubMed ID: 23760062
[TBL] [Abstract][Full Text] [Related]
14. Alterations in estrogen signalling pathways upon acquisition of anthracycline resistance in breast tumor cells.
Chewchuk S; Guo B; Parissenti AM
PLoS One; 2017; 12(2):e0172244. PubMed ID: 28196134
[TBL] [Abstract][Full Text] [Related]
15. Association of interferon regulatory factor-1, nucleophosmin, nuclear factor-kappaB, and cyclic AMP response element binding with acquired resistance to Faslodex (ICI 182,780).
Gu Z; Lee RY; Skaar TC; Bouker KB; Welch JN; Lu J; Liu A; Zhu Y; Davis N; Leonessa F; Brünner N; Wang Y; Clarke R
Cancer Res; 2002 Jun; 62(12):3428-37. PubMed ID: 12067985
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a receptor-negative, hormone-nonresponsive clone derived from a T47D human breast cancer cell line kept under estrogen-free conditions.
Murphy CS; Pink JJ; Jordan VC
Cancer Res; 1990 Nov; 50(22):7285-92. PubMed ID: 2224859
[TBL] [Abstract][Full Text] [Related]
17. C-myc gene expression alone is sufficient to confer resistance to antiestrogen in human breast cancer cells.
Venditti M; Iwasiow B; Orr FW; Shiu RP
Int J Cancer; 2002 May; 99(1):35-42. PubMed ID: 11948489
[TBL] [Abstract][Full Text] [Related]
18. Antagonism between estradiol and progestin on Bcl-2 expression in breast-cancer cells.
Kandouz M; Siromachkova M; Jacob D; Chretien Marquet B; Therwath A; Gompel A
Int J Cancer; 1996 Sep; 68(1):120-5. PubMed ID: 8895551
[TBL] [Abstract][Full Text] [Related]
19. Resistance to different antiestrogens is caused by different multi-factorial changes and is associated with reduced expression of IGF receptor Ialpha.
Brockdorff BL; Heiberg I; Lykkesfeldt AE
Endocr Relat Cancer; 2003 Dec; 10(4):579-90. PubMed ID: 14713268
[TBL] [Abstract][Full Text] [Related]
20. Hormonal modulation of HER-2/neu protooncogene messenger ribonucleic acid and p185 protein expression in human breast cancer cell lines.
Read LD; Keith D; Slamon DJ; Katzenellenbogen BS
Cancer Res; 1990 Jul; 50(13):3947-51. PubMed ID: 1972345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]